Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis

Oncogene volume 22, pages 5707–5711 (2003)Cite this article

Abstract

c-Myc promotes cellular proliferation, sensitizes cells to apoptosis and prevents differentiation. It binds cyclin T1 structurally and functionally from the positive transcription elongation factor b (P-TEFb). The cyclin-dependent kinase 9 (Cdk9) in P-TEFb then phosporylates the C-terminal domain of RNA polymerase II, which is required for the transition from initiation to elongation of eukaryotic transcription. Inhibiting P-TEFb blocks the transcription of its target genes as well as cellular proliferation and apoptosis induced by c-Myc.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Amati B, Littlewood TD, Evan GI and Land H . (1993). EMBO J., 12, 5083–5087.

  • Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N and Peterlin BM . (2001). Mol. Cell, 8, 327–337.

  • Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN and Cleveland JL . (2002). Genes Dev., 16, 2530–2543.

  • Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R and Magrath I . (1993). Nat. Genet., 5, 56–61.

  • Chao SH and Price DH . (2001). J. Biol. Chem., 276, 31793–31799.

  • Claassen GF and Hann SR . (1999). Oncogene, 18, 2925–2933.

  • Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D and Raffeld M . (1994). Cancer Res., 54, 3383–3386.

  • Eberhardy SR and Farnham PJ . (2001). J. Biol. Chem., 276, 48562–48571.

  • Eberhardy SR and Farnham PJ . (2002). J. Biol. Chem.

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC . (1992). Cell, 69, 119–128.

  • Grandori C, Cowley SM, James LP and Eisenman RN . (2000). Annu. Rev. Cell. Dev. Biol., 16, 653–699.

  • Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB and DePinho RA . (1999). Oncogene, 18, 1219–1226.

  • Juin P, Hueber AO, Littlewood T and Evan G . (1999). Genes Dev., 13, 1367–1381.

  • Kanazawa S, Okamoto T and Peterlin BM . (2000). Immunity, 12, 61–70.

  • Kim YK, Bourgeois CF, Isel C, Churcher MJ and Karn J . (2002). Mol. Cell. Biol., 22, 4622–4637.

  • Lee DK, Duan H and O'Chang C . (2001). J. Biol. Chem., 276, 9978–9984.

  • Lis JT, Mason P, Peng J, Price DH and Werner J . (2000). Genes Dev., 14, 792–803.

  • Nasi S, Ciarapica R, Jucker R, Rosati J and Soucek L . (2001). FEBS Lett., 490, 153–162.

  • Peukert K, Staller P, Schneider A, Carmichael G, Hanel F and Eilers M . (1997). EMBO J., 16, 5672–5686.

  • Price DH . (2000). Mol. Cell. Biol., 20, 2629–2634.

  • Ramanathan Y, Rajpara SM, Reza SM, Lees E, Shuman S, Mathews MB and Pe'ery T . (2001). J. Biol. Chem., 276, 10913–10920.

  • Sakamuro D and Prendergast GC . (1999). Oncogene, 18, 2942–2954.

  • Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL and Giordano A . (2002). Oncogene, 21, 4137–4148.

  • Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G and Nasi S . (1998). Oncogene, 17, 2463–2472.

  • Wei P, Garber ME, Fang SM, Fischer WH and Jones KA . (1998). Cell, 92, 451–462.

  • Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH and Brady JN . (2000). Mol. Cell. Biol., 20, 5077–5086.

Download references

Acknowledgements

We thank members of our laboratories for reagents and helpful comments on the manuscript. This work was supported by the grants from the Nora Eccles Treadwell Foundation and the NIH.

Author information

Authors and Affiliations

  1. Departments of Medicine, Microbiology and Immunology, Rosalind Russell Medical Research Center, University of California, San Francisco, CA, USA

    Satoshi Kanazawa & B Matija Peterlin

  2. Cancer Research Institute, University of California, San Francisco, CA, USA

    Laura Soucek & Gerard Evan

  3. Department of Molecular Genetics, Nagoya City University Medical School, Nagoya, Japan

    Satoshi Kanazawa & Takashi Okamoto

Authors
  1. Satoshi Kanazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Soucek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerard Evan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Matija Peterlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Matija Peterlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanazawa, S., Soucek, L., Evan, G. et al. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22, 5707–5711 (2003). https://doi.org/10.1038/sj.onc.1206800

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206800

Keywords

This article is cited by

Search

Advanced search

Quick links